Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 +0.00 (+0.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Long-Term Investments (2019 - 2021)

Updated

Jasper Therapeutics (JSPR) posted Long-Term Investments of $100.13 million for Q2 2021, down 0.3% from $100.42 million a year earlier and down 0.1% from the prior quarter.

Analysis

Jasper Therapeutics (JSPR) Long-Term Investments (2019 - 2021) Analysis & Trends

At the end of FY2020, Jasper Therapeutics' Long-Term Investments came in at $100.34 million, up 0.2% from FY2019.

  • In prior years, Jasper Therapeutics' Long-Term Investments was $100.15 million in FY2019.
  • According to Business Quant data, Long-Term Investments for the three prior quarters was $100.2 million (Q1 2021), $100.34 million (Q4 2020) and $100.35 million (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 266.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 297.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.56 Bn
10 Jasper Therapeutics 14.47 Mn -111.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 100.13 Mn
Mar 31, 2021 100.20 Mn
Dec 31, 2020 100.34 Mn
Sep 30, 2020 100.35 Mn
Jun 30, 2020 100.42 Mn
Mar 31, 2020 100.40 Mn
Dec 31, 2019 100.15 Mn
API Access

Jasper Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=JSPR&period=max&api_key=YOUR_API_KEY